![](data:image/svg+xml;charset=utf-8,<svg height="32" width="135" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
₹ 120.45
Open
122.45High
123.3Low
119.75Prev Close
122.45P/E
-Median P/E
31.46P/B
4.37Median P/B
4.43Market Cap
29.93BPEG
-Div.Yield
-Bid
120.25Ask
120.35Large Cap
29.93B Mkt. Cap.Volatility
-Beta
0.45Genie Says
Influencer Count
-| Days | BSE | NSE |
|---|
| 5 | 123.69 | 123.78 |
| 10 | 123.36 | 123.40 |
| 20 | 123.65 | 123.67 |
| 50 | 127.33 | 127.37 |
| 100 | 127.37 | 127.43 |
| 300 | 111.56 | 111.58 |
BSE
512529NSE
SEQUENTISIN
INE807F01027SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.
Rajaram Narayanan
Chief Executive Officer, Managing Director, Executive DirectorSaurav Bhala
Chief Financial OfficerPhillip Trott
Compliance Officer, Company SecretaryPrasad Lad
Vice President-Human Resources & AdminVedprakash Ragate
Additional Executive and Non-Independent DirectorYawar Abbas
Emerging marketsJose Filho
Latin America OperationsAlexis Goux
Global FormulationsAshish Kakabalia
Business Development and R&DAlan Kelly
United States Operations